EUVIMEDEUVIMED entdecken
Crossref

Antiviral opportunities of Mannich bases derived from triterpenic N ‐propargylated indoles

Anastasiya Petrova, Elena Tretyakova, Elmira Khusnutdinova, Oxana Kazakova, Alexander Slita, Vladimir Zarubaev, Xinyuan Ma, Hongwei Jin, Huan Xu, Sulong Xiao

Chemical Biology & Drug Design · 2024-01 · 103 (1)

DOI: 10.1111/cbdd.14370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 06.10.2023. Verfasst von Anastasiya Petrova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Ufa Institute of Chemistry UFRC RAS, Ufa, Russian Federation. Hauptthemen laut MEDLINE: Influenza A Virus, H1N1 Subtype, Oleanolic Acid. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Russian Foundation for Basic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oleanolic and glycyrrhetic acids alkyne derivatives were synthesized as a result of propargylation of the indole NH‐group condensed with the triterpene A‐ring, the following aminomethylation led to a series of Mannich bases. The synthesized compounds were tested for their potential inhibition of influenza A/PuertoRico/8/34 (H1N1) virus in Madin‐Darby canine kidney (MDCK) cell culture and SARS‐CoV‐2 pseudovirus in baby hamster kidney‐21‐human angiotensin‐converting enzyme 2 (BHK‐21‐hACE2) cells. Mannich bases of oleanolic and glycyrrhetic acids N ‐propargylated indoles 7 , 8 , and 12 were the most efficacious against influenza virus A with IC 50 7–10 μM together with a low toxicity (CC 50 > 145 μM) and high selectivity index SI value 20. Indolo‐oleanolic acid morpholine amide Mannich base holding N ‐methylpiperazine moiety 9 showed anti‐SARS‐CoV‐2 pseudovirus activity with EC 50 value of 14.8 μM. Molecular docking and dynamics modeling investigated the binding mode of the compounds 7 and 12 into the binding pocket of influenza A virus M2 protein and compound 9 into the RBD domain of SARS‐CoV‐2 spike glycoprotein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A Virus, H1N1 SubtypeOleanolic AcidAnimalsCricetinaeDogsHumansAntiviral AgentsIndolesMannich BasesMolecular Docking SimulationSARS-CoV-2Piperazines

Stichwörter der Autor:innen

Mannich reactionSARS-CoV-2indoleinfluenza H1N1triterpenoids

Substanzen

Antiviral AgentsIndolesMannich BasesOleanolic Acid1-methylpiperazinePiperazines

Autor:innen und Institutionen

  • Ufa Institute of Chemistry UFRC RAS, Ufa, Russian Federation.
  • Department of Virology, St. Petersburg Pasteur Institute of Epidemiology and Microbiology, Experimental Virology Laboratory, St. Petersburg, Russian Federation.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, China.

Förderung

  • National Natural Science Foundation of China
  • Russian Foundation for Basic Research

Zitieren

APA

Petrova, A., Tretyakova, E., Khusnutdinova, E., Kazakova, O., Slita, A., Zarubaev, V., Ma, X., Jin, H., Xu, H., & Xiao, S. (2024). Antiviral opportunities of Mannich bases derived from triterpenic N ‐propargylated indoles. Chemical Biology & Drug Design, 103(1). https://doi.org/10.1111/cbdd.14370

Vancouver

Petrova A, Tretyakova E, Khusnutdinova E, Kazakova O, Slita A, Zarubaev V, et al. Antiviral opportunities of Mannich bases derived from triterpenic N ‐propargylated indoles. Chemical Biology & Drug Design. 2024;103(1). doi:10.1111/cbdd.14370

BibTeX
@article{Petrova2024,
  author = {Petrova, Anastasiya and Tretyakova, Elena and Khusnutdinova, Elmira and Kazakova, Oxana and Slita, Alexander and Zarubaev, Vladimir and Ma, Xinyuan and Jin, Hongwei and Xu, Huan and Xiao, Sulong},
  title = {Antiviral opportunities of Mannich bases derived from triterpenic N ‐propargylated indoles},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  volume = {103},
  number = {1},
  doi = {10.1111/cbdd.14370}
}
Kostenlos starten →